：：：：：：：：：：：：：：：：：：：：）：：：：：：：：：：：：
中华临床感染病杂志2019年12月第12卷第6期ChinJClinInfectDis,December2019,Vol.12,No.6
?428?
(3):427435.DOI10.I016/j.jhep.2004.05.014.
年版)[J]?中华肝脏病杂志,2019,27(1)18-26.DOI10.
3760/cma.j.issn1007-3418..2019.01.006.[220]PengJW,LinGN,XiaoJJ,etal.HepatitisBvirusreactivation
LiverFailureandArtificiaLiverlGroup,ChineseSocietyofinhepatocellulacarcrinomapatientsundei^oingtranscatheter
InfectiousDiseases,ChineseMedicalAssociati,onSevereLiverarterichealmoembolizatitheronapy[J].AsiaPacJClinOncol,
DiseaseandArtificialLiverGroup,ChineseSocietyof2012,8(4)356-361.DOI10.1111/j.1743-7563.
Hepatology,ChineseMedicalAssociation.Guidelinefor2012.01534.
[221]KimJH,ParkJW,KimTH,etal.HepatitisBvirusreactivation
diagnosisandtreatmentofliverfailur[eJ].ChinJHepat,ol
afterthree-dimensionalconformalradiotherapyinpatientswith
2019,27(1):18-26.DOI10.3760/cma.j.issn.1007-3418.
2019.01.006.(inChinese)hepatitBisvirus-relathepaedtocellulacarcrinoma[J].IntJ
[211]SunP,DongX,ChengX,etal.Nucleot(s)ideanaloguesforRadiatOncolBiolPhys,2007,69(3)813-819.DOI10.1016/
hepatitBisvirus-relathepatoceledlularcarcinomaaftercurativej.ijrobp.2007.04.005.
treatment:asystematreviicewandmeta-analysis[J/OL].PLoS[222]YeoW,LamKC,ZeeB,etal.HepatitiBsreactivatinion
One,2014,9(7)el02761.DOI10.1371/joumal.patientswithhepatocellulacarcrinomaundergoingsystemic
pone.0102761.chemother[apyJ].AnnOncol,2004,15(11)1661-1666.
[212]YinJ,LiN,HanY,etal.EffectofantivirtraleatmentwithDOI:10.1093/annoncmdh430./
nucleotide/nucleosianalogsdeonpostoperatiprognosisveof[223]MaiwallR,KumarM.Preventionandtreatmentofrecurrent
hepatitisBvirus-relathepatoceedllulacarrcinoma:atwo-stagehepatitBisafterlivertransplant[Jation].JClinTranslHepatol,
longitudinclinialcalstudy[J].JClinOncol,2013,31(29):2016,4(1)54-65.DOI:10.14218/JCTH.2015.00041.
3647-3655.DOI10.1200/JCO.2012.48.5896.[224]CholongitEas,PapatheodorGV.idisHighgeneticbarriernucleos
(t)ideanalogue(s)forprophylaxfromishepatitisBvirus
[213]HuangG,LauWY,WangZG,etal.Antivirtheralapyimproves
postoperatisurvevivalinpatientswithhepatocellulacarcinroma:arecurrenceafterlivertransplantation:asystematicreview[J].
randomizedcontroltrledial[J].ArmSurg,2015,261(1)56-AmJTransplant2013,13,(2)353-362.DOI10.1111/j.
66.DOI10.1097/SLA.0000000000000858.1600-6143.2012.04315.
[214]WongJS,WongGL,TsoiKK,etal.Meta-analythesisefficacy[225]YiNJ,ChoiJY,SuhKS,etal.Post-transplantsequatioentnial
ofanti-viraltherapyinpreventionofrecurrenceaftercurativeentecavirmonotherapyfollowing1-yearcombinationtherapywith
hepatitBisimmunoglobulin[J].JGastroenter,2013ol,48(12):
treatmentofchronichepatitisB-relatedhepatocellulcarcarinoma
[J].AlimentPharmacolTher,2011,33(10)1104-1112.1401-1410.DOI10.1007/s00535-013-0761.
DOI10.1111/j.1365-2036.2011.04634.[226]TepermanLW,PoordadF,BzowejN,etal.Randomizedtrialof
[215]WuCY,ChenYJ,HoHJ,etal.Associationbetweennucleosideemtricitabine/tenofodisoprviroxilfumaratafeterhepatitisB
analoguesandriskofhepatitBisvirus-relatehepatocdellularimmunoglobulinwithdrawaaftlerlivertransplant[atiJ].onLiver
carcinomarecurrencfolleowingliverresecti[onJ].JAMA,2012,Transpl,2013,19(6):594-601.DOI10.1002/lt23628..
308(18)1906-1914.DOI10.1001/2012.jama.11975.[227]ChenG,LiuH,HuZQ,etal.Anewschemewithinfusionof
[216]JangJW,ChoiJY,BaeSH,etal.ArandomizedcontrolledhepatitisBimmunoglobulincombinedwithentecavirfor
studyofpreemptivelamivudineinpatientsreceivingtransarterialprophylaxisofhepatitBisvirusrecurrenceamonglivertransplant
chemo-lipiodoliz[atJ]ion.Hepatology,2006,43(2):233-240.recipients[J].EurJGastroenteHeparoltol,2015,27(8):901-
DOI10.1002/hep.21024.906.DOI10.1097/MEG.0000000000000388.
[217]SunHC,TangZY,WangL,etal.Postoperatiinteverferalphaon[228]中国医师协会器官移植医师分会，中华医学会器官移植学分
treatmentpostponedrecurrenceandimproveoverdallsurvivalin会.中国肝癌肝移植临床实践指南(2018版)[J].中华消化
patientsaftercurativeresectionofHBV-relatedhepatocellular外科杂志,2019,18(1):1-7.D0110.1053/j.gastro2018..
carcinoma:arandomizedclinicaltrial[J].JCancerResClin11.053.
Oncol,2006,132(7)458465.DOI10.1007/s00432-ChineseCollegeofTransplantDoctor,sChineseSocietyofOrgan
006-0091.TransplantatiChion.neseclinicalpracticeguidelinofeliver
[218]LaoXM,LuoG,YeLT,etal.Effectofsantiviratherlapyontransplantationforhepatocellulacarcirnoma(2018edition)[J].
hepatitBisvirusreactivationandliverfunctionafterresectionorChinJDigSurg,2019,18(l)l-7.DOI10.1053/j.gastro.
2018.11.053.(inChines)e
chemoembolizatforionhepatocellulcarcarinoma[J].LiverInt,
2013,33(4):595-604.DOI10.1111/Uv.12112.
[219]JangJW,ChoiJY,BaeSH,etal.Transartechemo-rial
（收稿日期:2019-11-19
lipiodolizaticanonreactivahepatetitisBvirusreplicatioinn
（本文编辑:彭芳金建华）
patientswithhepatocellulacarcinomar[J].JHepatol,2004,41 |
|
